Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000799767 | SCV000939445 | pathogenic | Charcot-Marie-Tooth Neuropathy X | 2021-09-19 | criteria provided, single submitter | clinical testing | This variant is also known as p.Ser42CysfsX45. For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the GJB1 protein in which other variant(s) (p.Tyr65*) have been determined to be pathogenic (PMID: 22464564). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. This premature translational stop signal has been observed in individual(s) with X-linked Charcot-Marie-Tooth disease type 1X (PMID: 22464564). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Ser42Cysfs*4) in the GJB1 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 242 amino acid(s) of the GJB1 protein. |
Inherited Neuropathy Consortium | RCV000789808 | SCV000929192 | uncertain significance | Charcot-Marie-Tooth disease | no assertion criteria provided | literature only | ||
Inherited Neuropathy Consortium Ii, |
RCV003447274 | SCV004174689 | uncertain significance | Charcot-Marie-Tooth disease X-linked dominant 1 | 2016-01-06 | no assertion criteria provided | literature only |